Genetic study of diabetic retinopathy: Recruitment methodology and analysis of baseline characteristics

Clinical and Experimental Ophthalmology

Volumn 42, Issue 5, 2014, Pages 486-493

  Kaidonis, Georgia ^a   Abhary, Sotoodeh ^a   Daniell, Mark ^b   Gillies, Mark ^e   Fogarty, Rhys ^a   Petrovsky, Nikolai ^a   Jenkins, Alicia ^c   Essex, Rohan ^g   Chang, John H ^f,h   Pal, Bishwanath ^h   Hewitt, Alex W ^d   Burdon, Kathryn P ^a   Craig, Jamie E ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^h MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Diabetic macular oedema; Diabetic retinopathy; Genome wide association study

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BODY MASS; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DIABETIC HYPERTENSION; DIABETIC MACULAR EDEMA; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; EYE EXAMINATION; EYE PHOTOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METHODOLOGY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; PHENOTYPE; QUESTIONNAIRE; VENOUS BLOOD; ADOLESCENT; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; MACULAR EDEMA; METABOLISM; MIDDLE AGED; PATIENT SELECTION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; PATIENT SELECTION; YOUNG ADULT;

EID: 84904740462     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/ceo.12239     Document Type: Article

References (30)

1. National Diabetes Data Group (U.S.), National Institute of Diabetes and Digestive and Kidney Diseases (U.S.), National Institutes of Health (U.S.). Diabetes in America. 1995.
2. National Association of Diabetes Centres. Australian National Diabetes Information Audit and Benchmarking: Final report 2009. 2010; 1-470.
3. Landers J, Henderson T, Abhary S, Craig J. Prevalence and associations of diabetic retinopathy in indigenous Australians within central Australia: the Central Australian Ocular Health Study. Clin Experiment Ophthalmol 2010; 38: 393-397.
4. Taylor HR, Xie J, Fox S, Dunn RA, Arnold A-L, Keeffe JE. The prevalence and causes of vision loss in Indigenous Australians: the National Indigenous Eye Health Survey. Med J Aust 2010; 192: 312-318.
5. Jaross N, Ryan P, Newland H. Incidence and progression of diabetic retinopathy in an Aboriginal Australian population: results from the Katherine Region Diabetic Retinopathy Study (KRDRS). Report no. 2. Clin Experiment Ophthalmol 2005; 33: 26-33.
6. Kobrin Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 2007; 14: 179-183.
7. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-986.
8. Mitchell P, Foran S, Foran J. Clinical Practice Guidelines for the Management of Diabetic Retinopathy. Canberra: National Health and Medical Research Council, 2008.
9. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997; 46: 1829-1839.
10. Arar NH, Freedman BI, Adler SG etal. Heritability of the severity of diabetic retinopathy: the FIND-Eye Study. Invest Ophthalmol Vis Sci 2008; 49: 3839-3845.
11. Grassi MA, Tikhomirov A, Ramalingam S, Below JE, Cox NJ, Nicolae DL. Genome-wide meta-analysis for severe diabetic retinopathy. Hum Mol Genet 2011; 20: 2472-2481.
12. Looker HC, Nelson RG, Chew E etal. Genome-wide linkage analyses to identify loci for diabetic retinopathy. Diabetes 2007; 56: 1160-1166.
13. Hallman DMD, Boerwinkle EE, Gonzalez VHV, Klein BEKB, Klein RR, Hanis CLC. A genome-wide linkage scan for diabetic retinopathy susceptibility genes in Mexican Americans with type 2 diabetes from Starr County, Texas. Diabetes 2007; 56: 1167-1173.
14. Abhary S, Hewitt AW, Burdon KP, Craig JE. A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes 2009; 58: 2137-2147.
15. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991; 98: 786-806.
16. Purcell SS, Cherny SSS, Sham PCP. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2002; 19: 149-150.
17. Sobrin L, Green T, Sim X etal. Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). Invest Ophthalmol Vis Sci 2011; 52: 7593-7602.
18. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
19. Abhary S, Burdon KP, Laurie KJ etal. Aldose reductase gene polymorphisms and diabetic retinopathy susceptibility. Diabetes Care 2010; 33: 1834-1836.
20. Bates DOD, Harper SJS. Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 2002; 39: 225-237.
21. Bonnefond A, Saulnier P-J, Stathopoulou MG etal. What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications? Plos ONE 2012; 8: e55921-1.
22. Mitchell P, Bandello F, Schmidt-Erfurth U etal. The RESTORE Study. Ophthalmology 2011; 118: 11-1.
23. Michaelides MM, Kaines AA, Hamilton RDR etal. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT Study). Ophthalmology 2010; 117: 1078-1087.
24. Huang Y-C, Lin J-M, Lin H-J etal. Genome-wide association study of diabetic retinopathy in a Taiwanese population. Ophthalmology 2011; 118: 642-648.
25. Fu Y-P, Hallman DM, Gonzalez VH etal. Identification of diabetic retinopathy genes through a genome-wide association study among Mexican-Americans from Starr County, Texas. J Ophthalmol 2010; 2010: 861291. doi: 10.1155/2010/861291.
26. Sheu WH-H, Kuo JZ, Lee I-T etal. Genome-wide association study in a Chinese population with diabetic retinopathy. Hum Mol Genet 2013; 22: 3165-3173.
27. Guey LT, Kravic J, Melander O etal. Power in the phenotypic extremes: a simulation study of power in discovery and replication of rare variants. Genet Epidemiol 2011; 35: 236-246.
28. Burdon KP, Macgregor S, Hewitt AW etal. Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat Genet 2011; 43: 574-578.
29. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995; 102: 7-16.
30. Mitchell PP, Moffitt PP. Update and implications from the Newcastle diabetic retinopathy study. Aust N Z J Ophthalmol 1990; 18: 13-17.